This content is machine translated Psoriasis treatment with biologics What are the latest trends? Novel oral therapies are currently being researched – promising data from clinical trials is now available. In the field of approved, subcutaneously administered IL-23 and IL-17 antagonists, current real-world data...…
View Post 6 min This content is machine translated Urticaria & urticaria-like exanthema Case studies from pediatric dermatology The lifetime prevalence of urticaria is almost 20%. Second-generation antihistamines are also recommended as first-line therapy for pediatric patients. However, pediatric patients with itchy wheals are not always suffering from...…
View Post 6 min This content is machine translated Vitiligo in children and adolescents Just don’t bury your head in the sand! This dermatosis, which is based on the destruction of melanocytes, can occur at any age – however, it usually affects 10-30 year olds and in over a third of cases...…
View Post 7 min This content is machine translated Moderate to severe chronic hand eczema Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland In the phase III DELTA 1 and 2 studies, delgocitinib cream showed a rapid onset of efficacy – at week 16, half of the patients achieved a 75% improvement in...…
View Post 3 min This content is machine translated Gram-negative foot infection Not to be taken lightly Infections of wounds in the foot area are common and correct classification is sometimes a challenge. In Gram-negative foot infections, clinical findings form the backbone of the diagnosis. Local therapy...…
View Post 4 min This content is machine translated Biologics for atopic dermatitis Th2 cytokines in focus: proven and new targets The range of antibody therapies for atopic dermatitis (AD) has expanded once again in Europe. In addition to dupilumab and tralokinumab, lebrikizumab is another biologic available in this country that...…
View Post 4 min This content is machine translated Oral JAK-i in atopic dermatitis Benefits and risks: What does the current data say? Although there have been no recent approvals of oral JAK inhibitors (JAK-i) for atopic dermatitis (AD), some interesting study findings have been published. These shed light on the safety of...…
View Post 4 min This content is machine translated Prurigo nodularis Retrospective analyses of large data sets from everyday practice Prurigo nodularis (PN) is a chronic inflammatory skin disease that manifests itself as extremely itchy hard nodules. Prof. Dr. med. Dr. rer nat. Enno Schmidt from the University Hospital Schleswig-Holstein...…
View Post 6 min This content is machine translated Chronic hand eczema Changing therapy landscape – a lot is happening Inflamed, itchy and sometimes painful skin lesions on the hands can significantly impair quality of life. If chronic hand eczema proves to be refractory to topical treatment, systemic therapy is...…
View Post 10 min This content is machine translated Cutaneous lupus erythematosus From diagnostic workup to successful treatment Cutaneous lupus erythematosus (CLE) is a rare autoimmune disease with a heterogeneous spectrum of clinical manifestations on the skin. Prof. Dr. med. Luca Borradori, Chief Physician and Clinic Director of...…
View Post 9 min This content is machine translated Psoriasis in locations that are difficult to treat New study data on IL-23 inhibition When psoriasis manifests in palmoplantar and intertriginous regions or on the nails, this often poses a therapeutic challenge. Several recently presented analyses on the effects of anti-IL-23p19 antibodies currently approved...…
